Cases of respiratory syncytial virus, or RSV, are widespread across the area – even as providers at Pediatric Care Specialists continue seeing young patients for a continued trend of "walking ...
Researchers report that immunity against pertussis (whooping cough) was sustained 5 years after receipt of a recombinant ...
The first study, published yesterday in Clinical Infectious Diseases, includes results of a phase 3 clinical trial (MELODY), ...
Now that colder temperatures have arrived, the Illinois Department of Public Health (IDPH) is reminding Illinoisans to ...
Newborns whose mothers have not received the RSV vaccine, should receive Nirsevimab between October and March. Public health leaders stress one of the best ways to reduce transmission of viruses is to ...
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness.
Use of nirsevimab was associated with an approximately 80% reduction in illness due to respiratory syncytial virus (RSV) ...